Debug Stats | ### Total Build Time: 46 ms 42.004 KB CONCEPT_NAME gt=2 ms Completed: 2 ms rowSize= 420 bytesCONCEPT_SOLR_HIT_STATS gt=0 Completed: 0 ms rowSize= 14 bytesCONCEPT_DEFINITION gt=0 Completed: 0 ms rowSize= 390 bytes- Skipping details on:
CONCEPT_SYNONYM gt=NONE 0 Completed: 0 ms rowSize= 0 bytes - Skipping details on:
CONCEPT_TEXT gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_SEMANTIC_TYPE gt=0 Completed: 0 ms rowSize= 188 bytes- Skipping details on:
CONCEPT_NAMESPACE gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_PARENTS gt=2 ms Completed: 2 ms rowSize= 565 bytesCONCEPT_CHILDREN gt=0 Completed: 0 ms rowSize= 8 bytesCONCEPT_ANCESTRAL_ROOTS gt=4 ms Completed: 4 ms rowSize= 2.815 KBCONCEPT_RELATIONSHIPS gt=23 ms Completed: 23 ms rowSize= 15.766 KBCONCEPT_GENES gt=12 ms Completed: 12 ms rowSize= 20.698 KBCONCEPT_XREFS gt=2 ms Completed: 2 ms rowSize= 1.163 KBCONCEPT_ANCILLARY gt=1 ms Completed: 1 ms rowSize= 14 bytes- Reload Stats
|
Relationships (63)
Relation Types: diso_to_anat : 30 diso_to_chem : 3 diso_to_diso : 28 diso_to_phen : 2
Relationships: none : 15 is_abnormal_cell_of_disease : 6 is_finding_of_disease : 3 is_normal_cell_origin_of_disease : 5 is_normal_tissue_origin_of_disease : 2 is_not_abnormal_cell_of_disease : 2 is_not_normal_cell_origin_of_disease : 4 is_primary_anatomic_site_of_disease : 2 isa : 7 may_be_abnormal_cell_of_disease : 4 may_be_associated_disease_of_disease : 1 may_be_cytogenetic_abnormality_of_disease : 3 may_be_finding_of_disease : 5 may_be_molecular_abnormality_of_disease : 3 permuted_term_of : 1 | |
DISO_to_DISO | 55 | |
Lymphoma, T-Cell C0079772 | DISO_to_DISO | 34 | |
Lymphoma, T-Cell C0079772 | DISO_to_DISO | 25 | |
Lymphoma, T-Cell, Peripheral C0079774 | DISO_to_DISO | 21 | |
Complication Aspects C1171258 | DISO_to_DISO | 13 | |
Lymphoma, T-Cell, Peripheral C0079774 | DISO_to_PHEN | 11 | |
genetic aspects C0017399 | DISO_to_PHEN | 10 | |
genetic aspects C0017399 | DISO_to_ANAT | 6 | |
Helper-Inducer T-Lymphocyte C0018894 | DISO_to_ANAT | 6 | |
T-Lymphocyte C0039194 | DISO_to_ANAT | 5 | |
Lymph Nodes C0024204 | DISO_to_CHEM | 5 | |
Antigens, CD C0003322 | DISO_to_ANAT | 4 | |
In Blood C0005768 | DISO_to_ANAT | 4 | |
Plasma Cells C0032112 | DISO_to_CHEM | 4 | |
Apoptosis Regulator C1564881 | DISO_to_CHEM | 4 | |
Neprilysin C0025250 | DISO_to_ANAT | | is_abnormal_cell_of_disease |
Atypical lymphocyte C0221277 | DISO_to_ANAT | | is_normal_cell_origin_of_disease |
CD4 Positive T Lymphocytes C0039215 | DISO_to_ANAT | | is_not_abnormal_cell_of_disease |
Cells, Reed-Sternberg C0085133 | DISO_to_ANAT | | is_normal_tissue_origin_of_disease |
HEMOLYMPHORETICULAR TISSUE C1512398 | DISO_to_ANAT | | is_primary_anatomic_site_of_disease |
Hematopoietic and Lymphatic System C1512394 | DISO_to_ANAT | | is_normal_cell_origin_of_disease |
Hematopoietic and Lymphoid Cell C1512385 | DISO_to_ANAT | | is_primary_anatomic_site_of_disease |
Lymphatic System C0024235 | DISO_to_ANAT | | is_normal_tissue_origin_of_disease |
Lymphatic Tissue C0024296 | DISO_to_ANAT | | is_normal_cell_origin_of_disease |
Lymphocyte C0024264 | DISO_to_ANAT | | is_not_normal_cell_origin_of_disease |
Myeloid Cells C0887899 |
|
Genes (15)
Species: human : 15 | |
Human | PDCD1LG2 | 80380 | programmed cell death 1 ligand 2 | Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia | Human | LEF1 | 51176 | lymphoid enhancer-binding factor 1 | Of the Th1-like PTCL studied, 33 of 42 (79%) were immunoreactive for LEF-1 and 32 of 42 (76%) were immunoreactive for TCF-1, including most cases of angioimmunoblastic lymphoma and all cases of lymphoepithelioid lymphoma. | Human | CXCL13 | 10563 | chemokine (C-X-C motif) ligand 13 | The similar pattern of expression of CXCL13 and PD-1 in angioimmunoblastic T-cell lymphoma provides further evidence that AITL is a neoplasm derived from germinal-center T-helper cells | Human | CXCR4 | 7852 | chemokine (C-X-C motif) receptor 4 | Tumors previously identified as exhibiting a composite Th1-like immunophenotype, which include angioimmunoblastic lymphoma, lymphoepithelioid lymphoma, and other peripheral T-cell lymphomas now termed unspecified, were positive for CXCR4/CD184 in 7 (17%) of 41 cases. | Human | VEGFA | 7422 | vascular endothelial growth factor A | VEGF is expressed not only by reactive cells, but also by neoplastic cells, and NF-kappaB activation is uncommon in angioimmunoblastic lymphoma, as suggested by frequent exclusively cytoplasmic c-REL localization | Human | TNFRSF4 | 7293 | tumor necrosis factor receptor superfamily, member 4 | In AILD, almost all cases were immunoreactive for OX40/CD134 (96%) and for CXCR3 (89%). CD134/OX40 expression is characteristic of certain entities (angioimmunoblastic lymphoma, angiocentric T-NHL) and a subset of T-NHLs of unspecified type, whereas CD30 expression is characteristic of ALCL and a largely non-overlapping subset of T-NHLs of unspecified type. In contrast, large numbers of OX40/CD134(+) tumors cells were typical of angioimmunoblastic lymphoma (15/16 [94%]), angiocentric lymphoma (4/4), a subset of large-cell lymphomas (10/21 [48%]), and lymphomas with a prominent histiocytic component (6/7 [86%]). | Human | TCF7 | 6932 | transcription factor 7 (T-cell specific, HMG-box) | Of the Th1-like PTCL studied, 33 of 42 (79%) were immunoreactive for LEF-1 and 32 of 42 (76%) were immunoreactive for TCF-1, including most cases of angioimmunoblastic lymphoma and all cases of lymphoepithelioid lymphoma. | Human | SYCP1 | 6847 | synaptonemal complex protein 1 | A majority (9 of 15) of T- NHLs (9 peripheral T-cell lymphomas, 2 lymphoblastic T-cell lymphomas, and 4 cases of AILD) expressed HOM-TES-14/SCP-1. | Human | REL | 5966 | v-rel avian reticuloendotheliosis viral oncogene homolog | VEGF is expressed not only by reactive cells, but also by neoplastic cells, and NF-kappaB activation is uncommon in angioimmunoblastic lymphoma, as suggested by frequent exclusively cytoplasmic c-REL localization | Human | RAG2 | 5897 | recombination activating gene 2 | Expression of human recombination activating genes (RAG-1 and RAG-2) in angioimmunoblastic lymphadenopathy and anaplastic large cell lymphoma of T-type. In order to determine the genotypic maturation status of the proliferating lymphoid cells in angioimmunoblastic lymphadenopathy (AILD) and in anaplastic large cell lymphoma of T-type (T-ALC), recombinase activating gene (RAG-1 and RAG-2) expression was assessed in six AILD and five T-ALC cases using a sensitive reverse transcriptase (RT) and competitive (C) polymerase chain reaction (PCR). | Human | RAG1 | 5896 | recombination activating gene 1 | In order to determine the genotypic maturation status of the proliferating lymphoid cells in angioimmunoblastic lymphadenopathy (AILD) and in anaplastic large cell lymphoma of T-type (T-ALC), recombinase activating gene (RAG-1 and RAG-2) expression was assessed in six AILD and five T-ALC cases using a sensitive reverse transcriptase (RT) and competitive (C) polymerase chain reaction (PCR). Expression of human recombination activating genes (RAG-1 and RAG-2) in angioimmunoblastic lymphadenopathy and anaplastic large cell lymphoma of T-type. | Human | NFKB1 | 4790 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | VEGF is expressed not only by reactive cells, but also by neoplastic cells, and NF-kappaB activation is uncommon in angioimmunoblastic lymphoma, as suggested by frequent exclusively cytoplasmic c-REL localization | Human | MAF | 4094 | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog | Angioimmunoblastic T-cell lymphoma(AILT) shows c-Maf expression and provide new insight into the pathogenesis of AILT suggesting c-Maf to be a useful diagnostic marker | Human | CCR4 | 1233 | chemokine (C-C motif) receptor 4 | Among PTCL-U, CCR4 type, CXCR3 type and CCR3 type had prognoses equivalent to ATLL, AILD and ALCL, respectively (P<0.0001). | Human | MS4A1 | 931 | membrane-spanning 4-domains, subfamily A, member 1 | By applying triple immunofluorescent staining with antibodies directed against T-cell receptor Vbeta-family-specific epitopes, we investigated T-cell populations in AILD and their localisation in the tissue in relation to B cells (CD20) and follicular dendritic cells (CD21). |
|